SILO PHARMA, INC. Common Stock, Capital Shares Reserved for Future Issuance
SILO PHARMA, INC. (SILO) had Common Stock, Capital Shares Reserved for Future Issuance of 10.00 thousand shares as of 2020-07-15, per its 10-Q filed 2020-11-05.
Discontinued › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2021-05-17
- 2020-07-15: Common Stock, Capital Shares Reserved for Future Issuance 10.00K shares.
- 2020-04-30: Common Stock, Capital Shares Reserved for Future Issuance 7.63M shares.
- 2020-04-17: Common Stock, Capital Shares Reserved for Future Issuance 7.63M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2020-07-15 | 10.00K shares 10-Q · filed 2020-11-05 |
| 2020-04-30 | 7.63M shares 10-K/A · filed 2021-05-17 |
| 2020-04-17 | 7.63M shares 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |